ABSTRACT
Objective COVID-19 appears to have caused less severe outbreaks in many low- and middle-income countries (LMIC) compared with high-income countries, possibly because of differing demographics, socio-economics, surveillance, and policy responses. Here, we investigate the role of multiple factors on COVID-19 dynamics in the Philippines, a LMIC that has had a relatively severe COVID-19 outbreak.
Methods We applied an age-structured compartmental model that incorporated time-varying mobility, testing, and personal protective behaviors (through a “Minimum Health Standards” policy, MHS) to represent the Philippines COVID-19 epidemic nationally and for three highly affected regions (Calabarzon, Central Visayas, and the National Capital Region). We estimated effects of control measures, key epidemiological parameters, and interventions.
Findings Population age structure, contact rates, mobility, testing, and MHS were sufficient to explain the Philippines epidemic based on the good fit between modelled and reported cases, hospitalisations, and deaths. Several of the fitted epidemiological parameters were consistent with those reported in high-income settings. The model indicated that MHS reduced the probability of transmission per contact by 15-26%. The February 2021 case detection rate was estimated at ∼9%, population recovered at ∼12%, and scenario projections indicated high sensitivity to MHS adherence.
Conclusions COVID-19 dynamics in the Philippines are driven by age, contact structure, mobility, and MHS adherence, and the epidemic can be understood within a similar framework as for high-income settings. Continued compliance with low-cost MHS should allow the Philippines to maintain epidemic control until vaccines are widely distributed, but disease resurgence could occur due to low population immunity and detection rates.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the World Health Organization Regional Office for the Western Pacific to provide modelling advice to Member States. JMS is supported by a NASA Ecological Forecasting grant (NNX17AI21G). EDLT, TRT, MRJEE, and RFRS are supported by a project grant from the Philippine Council for Health Research and Development, Department of Science and Technology, Philippines. JMT is supported by an Early Career Fellowship from the National Health and Medical Research Council (APP1142638). The funding bodies had no role in the study design, analysis, interpretation of data, and in writing the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No IRB oversight was needed for this study.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Updated results to add predictions for January and February 2021. Added clarifying text and an additional supplemental figure.
Data Availability
The data analysed during the current study and model code are publicly available.
List of abbreviations
- CDR
- Case detection rate
- COVID-19
- Coronavirus disease 2019
- HIC
- High-income countries
- ICU
- Intensive care unit
- LMIC
- Low- and middle-income countries
- MHS
- Minimum Health Standards
- NPI
- Non-pharmaceutical intervention
